AIDS and Behavior

, Volume 17, Supplement 2, pp 156–170 | Cite as

Correlates of Retention in HIV Care After Release from Jail: Results from a Multi-site Study

  • Amy L. Althoff
  • Alexei Zelenev
  • Jaimie P. Meyer
  • Jeannia Fu
  • Shan-Estelle Brown
  • Panagiotis Vagenas
  • Ann K. Avery
  • Jacqueline Cruzado-Quiñones
  • Anne C. Spaulding
  • Frederick L. Altice
Original Paper


Retention in care is key to effective HIV treatment, but half of PLWHA in the US are continuously engaged in care. Incarcerated individuals are an especially challenging population to retain, and empiric data specific to jail detainees is lacking. We prospectively evaluated correlates of retention in care for 867 HIV-infected jail detainees enrolled in a 10-site demonstration project. Sustained retention in care was defined as having a clinic visit during each quarter in the 6 month post-release period. The following were independently associated with retention: being male (AOR = 2.10, p ≤ 0.01), heroin use (AOR 1.49, p = 0.04), having an HIV provider (AOR 1.67, p = 0.02), and receipt of services: discharge planning (AOR 1.50, p = 0.02) and disease management session (AOR 2.25, p ≤ 0.01) during incarceration; needs assessment (AOR 1.59, p = 0.02), HIV education (AOR 2.03, p ≤ 0.01), and transportation assistance (AOR 1.54, p = 0.02) after release. Provision of education and case management services improve retention in HIV care after release from jail.


HIV infection Jail Retention in care Adherence Secondary prevention 



Enhancing Linkages to HIV Primary Care Services Initiative is a HRSA-funded Special Project of National Significance. Funding for this research was also provided through career development grants from the National Institute on Drug Abuse (K24 DA017072, FLA and K23 DA033858, JPM), research grants from the National Institute on Alcohol Abuse and Alcoholism (R01 AA018944, FLA), institutional research training grants from the NIMH (T32 MH020031, JPM) and NIAID (T32 AI007517, ALA). The funding sources played no role in study design, data collection, data analysis, data interpretation, writing of the manuscript or the decision to submit the paper for publication.


  1. 1.
    Centers for Disease Control and Prevention. Advancing HIV prevention initiative. Centers for Disease Control and Prevention; 2005.Google Scholar
  2. 2.
    Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.PubMedCrossRefGoogle Scholar
  3. 3.
    Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis. 2008;198(1):59–67.PubMedCrossRefGoogle Scholar
  4. 4.
    Joint United Nations Programme on HIV/AIDS. Getting to zero. 2010.Google Scholar
  5. 5.
    Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010;24(17):2665–78.PubMedCrossRefGoogle Scholar
  6. 6.
    Giordano TP, Gifford AL, White AC, Suarez-Almazor ME, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Chen NE, Meyer JP, Avery AK, Draine J, Flanigan TP, Lincoln T, et al. Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav. 2011. doi: 10.1007/s10461-011-0080-2.
  8. 8.
    Meyer JP, Chen NE, Springer SA. HIV treatment in the criminal justice system: critical knowledge and intervention gaps. AIDS Res Treat. 2011;2011:680617.PubMedGoogle Scholar
  9. 9.
    Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120(1):84–8.PubMedGoogle Scholar
  11. 11.
    Baillargeon JG, Giordano TP, Harzke AJ, Baillargeon G, Rich JD, Paar DP. Enrollment in outpatient care among newly released prison inmates with HIV infection. Public Health Rep. 2010;125(Suppl 1):64–71.PubMedGoogle Scholar
  12. 12.
    Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301(8):848–57.PubMedCrossRefGoogle Scholar
  13. 13.
    Baillargeon J, Giordano TP, Harzke AJ, Spaulding AC, Wu ZH, Grady JJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS. 2010;24(6):389–94.PubMedCrossRefGoogle Scholar
  14. 14.
    Pai NP, Estes M, Moodie EE, Reingold AL, Tulsky JP. The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail. PLoS One. 2009;4(9):e7115.PubMedCrossRefGoogle Scholar
  15. 15.
    Draine J, Ahuja D, Altice FL, Arriola KJ, Avery AK, Beckwith CG, et al. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011;23(3):366–77.PubMedCrossRefGoogle Scholar
  16. 16.
    Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. 2011.Google Scholar
  17. 17.
    Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.PubMedCrossRefGoogle Scholar
  18. 18.
    Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.PubMedGoogle Scholar
  19. 19.
    McLellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise D. The addiction severity index at 25: origins, contributions and transitions. Am J Addict. 2006;15(2):113–24.PubMedCrossRefGoogle Scholar
  20. 20.
    McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33.PubMedCrossRefGoogle Scholar
  21. 21.
    McGahan P, Griffith J, Parente R, McLellan T. Addiction severity index composite score manual. The University of Pennsylvania/Veterans Administration Center for Studies of Addiction. 1986.Google Scholar
  22. 22.
    Calsyn DA, Saxon AJ, Bush KR, Howell DN, Baer JS, Sloan KL, et al. The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug Alcohol Depend. 2004;76(2):165–71.PubMedCrossRefGoogle Scholar
  23. 23.
    de Voux A, Spaulding AC, Beckwith C, Avery A, Williams C, Messina LC, et al. Early identification of HIV: empirical support for jail-based screening. PLoS One. 2012;7(5):e37603.PubMedCrossRefGoogle Scholar
  24. 24.
    Macgowan R, Margolis A, Richardson-Moore A, Wang T, Lalota M, French PT, et al. Voluntary rapid human immunodeficiency virus (HIV) testing in jails. Sex Transm Dis. 2009;36(Suppl 2):S9–13.PubMedGoogle Scholar
  25. 25.
    Jackman S. Estimation and inference via Bayesian simulation: an introduction to Markov Chain Monte Carlo. Am J Pol Sci. 2000;44:375–404.CrossRefGoogle Scholar
  26. 26.
    Manfred J, editor. On testing the missing at random assumption. Berlin: Springer; 2006.Google Scholar
  27. 27.
    Enders CK. Applied missing data analysis. New York: Guilford Press; 2010.Google Scholar
  28. 28.
    Fu J, Herme M, Wickersham J, Zelenev A, Althoff A, Zaller N, et al. Understanding the revolving door: factors associated with recidivism among HIV-infected jail detainees. AIDS Behav. 2012.Google Scholar
  29. 29.
    Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(5):651–81.PubMedCrossRefGoogle Scholar
  30. 30.
    DHHS Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. 2009.Google Scholar
  31. 31.
    Vlahov D, Putnam S. From corrections to communities as an HIV priority. J Urban Health. 2006;83(3):339–48.PubMedCrossRefGoogle Scholar
  32. 32.
    Stephenson BL, Wohl DA, McKaig R, Golin CE, Shain L, Adamian M, et al. Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS. 2006;17(2):103–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRefGoogle Scholar
  34. 34.
    Stone VE. HIV/AIDS in women and racial/ethnic minorities in the U.S. Curr Infect Dis Rep. 2012;14(1):53–60.PubMedCrossRefGoogle Scholar
  35. 35.
    Maruschak L. HIV in prisons, 2007–2008. U.S. Department of Justice: Bureau of Justice Statistics; 2009, contract no. NCJ 228307.Google Scholar
  36. 36.
    Jones AS, Lillie-Blanton M, Stone VE, Ip EH, Zhang Q, Wilson TE, et al. Multi-dimensional risk factor patterns associated with non-use of highly active antiretroviral therapy among human immunodeficiency virus-infected women. Womens Health Issues. 2010;20(5):335–42.PubMedCrossRefGoogle Scholar
  37. 37.
    Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis. 2009;199(7):991–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, et al. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis. 2011;203(4):442–51.PubMedCrossRefGoogle Scholar
  39. 39.
    Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48(2):248–56.PubMedCrossRefGoogle Scholar
  40. 40.
    Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012;60(1):77–82.PubMedCrossRefGoogle Scholar
  41. 41.
    Springer SA, Chen S, Altice F. Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Care. 2009;21(8):976–83.PubMedCrossRefGoogle Scholar
  42. 42.
    Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.PubMedGoogle Scholar
  43. 43.
    Traeger L, O’Cleirigh C, Skeer MR, Mayer KH, Safren SA. Risk factors for missed HIV primary care visits among men who have sex with men. J Behav Med. 2012;35(5):548–56.PubMedCrossRefGoogle Scholar
  44. 44.
    James DJ. Bureau of Justice Statistics Special Report: Profile of Jail Inmates, 2002. U.S. Department of Justice; 2004, contract no. NCJ 201932.Google Scholar
  45. 45.
    Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.PubMedCrossRefGoogle Scholar
  46. 46.
    Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.PubMedCrossRefGoogle Scholar
  47. 47.
    Milloy MJ, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.PubMedCrossRefGoogle Scholar
  48. 48.
    Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.PubMedCrossRefGoogle Scholar
  49. 49.
    Vlassova N, Angelino AF, Treisman GJ. Update on mental health issues in patients with HIV infection. Curr Infect Dis Rep. 2009;11(2):163–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423–31.PubMedCrossRefGoogle Scholar
  51. 51.
    Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817–33.PubMedCrossRefGoogle Scholar
  52. 52.
    Flanigan TP, Kim JY, Zierler S, Rich J, Vigilante K, Bury-Maynard D. A prison release program for HIV-positive women: linking them to health services and community follow-up. Am J Public Health. 1996;86(6):886–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Hammett T, Kennedy S, Kuck S. National survey of infectious diseases in correctional facilities’ HIV and sexually transmitted diseases: US Department of Justice (unpublished data). Department of Justice; 2007, contract no. NCJ 217736.Google Scholar
  54. 54.
    Zaller ND, Fu JJ, Nunn A, Beckwith CG. Linkage to care for HIV-infected heterosexual men in the United States. Clin Infect Dis. 2011;52(Suppl 2):S223–30.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Amy L. Althoff
    • 1
  • Alexei Zelenev
    • 1
  • Jaimie P. Meyer
    • 1
    • 5
  • Jeannia Fu
    • 1
    • 6
  • Shan-Estelle Brown
    • 1
  • Panagiotis Vagenas
    • 1
  • Ann K. Avery
    • 2
  • Jacqueline Cruzado-Quiñones
    • 3
  • Anne C. Spaulding
    • 4
  • Frederick L. Altice
    • 1
    • 7
  1. 1.AIDS ProgramYale University School of MedicineNew HavenUSA
  2. 2.Infectious DiseasesCase Western Reserve University School of MedicineClevelandUSA
  3. 3.New York City Department of Public HealthNew YorkUSA
  4. 4.EpidemiologyEmory University Rollins School of Public HealthAtlantaUSA
  5. 5.Biostatistics and EpidemiologyYale University School of Public HealthNew HavenUSA
  6. 6.Public HealthYale University School of Public HealthNew HavenUSA
  7. 7.Epidemiology of Microbial DiseasesYale University School of Public HealthNew HavenUSA

Personalised recommendations